| Overview of Monoamine Transporters S Aggarwal, OV Mortensen Current Protocols in Pharmacology 79 (1), 12.16.1-12.16.17, 2018 | 118 | 2018 |
| Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023 | 113 | 2023 |
| Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: a photoaffinity labeling study with the bupropion analogue [125I]-SADU-3-72 A Pandhare, AK Hamouda, B Staggs, S Aggarwal, PK Duddempudi, ... Biochemistry 51 (12), 2425-2435, 2012 | 33 | 2012 |
| Identification of a novel allosteric modulator of the human dopamine transporter S Aggarwal, X Liu, C Rice, P Menell, PJ Clark, N Paparoidamis, Y Xiao, ... ACS chemical neuroscience 10 (8), 3718-3730, 2019 | 28 | 2019 |
| Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for Gq/11 class G proteins MM Meleka, AJ Edwards, J Xia, SA Dahlen, I Mohanty, M Medcalf, ... Pharmacological research 141, 264-275, 2019 | 22 | 2019 |
| Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors HR Arias, D Feuerbach, KM Targowska-Duda, S Aggarwal, DJ Lapinsky, ... Neurochemistry international 61 (8), 1433-1441, 2012 | 20 | 2012 |
| (±)-2-(N-tert-Butylamino)-3′-[125I]-iodo-4′-azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion … DJ Lapinsky, S Aggarwal, TL Nolan, CK Surratt, JR Lever, R Acharya, ... Bioorganic & medicinal chemistry letters 22 (1), 523-526, 2012 | 16 | 2012 |
| A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone DJ Lapinsky, S Aggarwal, Y Huang, CK Surratt, JR Lever, JD Foster, ... Bioorganic & medicinal chemistry 17 (11), 3770-3774, 2009 | 15 | 2009 |
| NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: Featured Updates to the NCCN Guidelines NR Abu-Rustum, CM Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (12), 1224-1233, 2023 | 11 | 2023 |
| Functional characterization of the dopaminergic psychostimulant sydnocarb as an allosteric modulator of the human dopamine transporter S Aggarwal, MH Cheng, JM Salvino, I Bahar, OV Mortensen Biomedicines 9 (6), 634, 2021 | 9 | 2021 |
| Development of clickable photoaffinity ligands for metabotropic glutamate receptor 2 based on two positive allosteric modulator chemotypes SD Hellyer, S Aggarwal, ANY Chen, K Leach, DJ Lapinsky, KJ Gregory ACS chemical neuroscience 11 (11), 1597-1609, 2020 | 7 | 2020 |
| Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats JK Shaw, I Pamela Alonso, SI Lewandowski, MO Scott, BM O’Connor, ... Neuropsychopharmacology 46 (10), 1757-1767, 2021 | 6 | 2021 |
| Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in Caenorhabditis elegans through interactions with the dopamine transporter DAT-1 O Refai, S Aggarwal, MH Cheng, Z Gichi, JM Salvino, I Bahar, RD Blakely, ... Molecular Pharmacology 101 (3), 123-131, 2022 | 5 | 2022 |
| Discovery and Development of Monoamine Transporter Ligands S Aggarwal, OV Mortensen Drug Development in Psychiatry, 101-129, 2023 | 1 | 2023 |
| Site-specific Crosslinking Coupled with Mass Spectrometry as a Structural Tool in Studies of the Human α1 Glycine Receptor RJ Veeramachaneni, CA Donelan, KA Tomcho, S Aggarwal, DJ Lapinsky, ... bioRxiv, 2020.06. 29.178681, 2020 | 1 | 2020 |
| Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments H Nguyen, MH Cheng, JY Lee, S Aggarwal, OV Mortensen, I Bahar Current Research in Physiology 7, 100125, 2024 | | 2024 |
| Cervical Cancer, Version 1.2024 Featured Updates to the NCCN Guidelines NR Abu-Rustum, CM Yashar, R Arend, E Barber, K Bradley, R Brooks, ... JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK 21 (12), 1225-1233, 2023 | | 2023 |
| Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in C. elegans through Interactions with the Dopamine Transporter DAT-1 O Refai, S Aggarwal, MH Cheng, Z Gichi, JM Salvino, I Bahar, RD Blakely, ... Molecular Pharmacology, 2021 | | 2021 |
| Structure-function studies of a novel allosteric site of the dopamine transporter as a target for alternative therapeutics against cocaine use disorder S Aggarwal, X Liu, C Rice, S Kortagere, J Salvino, O Mortensen ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
| Abstract P1-10-05: Analysis of genetic mutation in ethnically diverse population with Breast and ovarian cancer: Single institution experience S Aggarwal, C Chu, M Ngumi Cancer Research 79 (4_Supplement), P1-10-05-P1-10-05, 2019 | | 2019 |
